caa a22 4500 477072496 CHVBK 20180405111430.0 cr unu---uuuuu 170330e19961101xx s 000 0 eng 10.1007/BF00050992 doi (NATIONALLICENCE)springer-10.1007/BF00050992 Radiofrequency catheter ablation of supraventricular tachycardias in patients with hypertrophic cardiomyopathy [Elektronische Daten] [Osamu Kinoshita, Morie Sekiguchi, Mitsuaki Isobe, Hiroaki Takenaka, Yoshikazu Yazaki, Hiroshi Imamura] Summary: Supraventricular tachycardias, as well as ventricular tachycardia, are critical in patients with hypertrophic cardiomyopathy. Anti-arrhythmic agents often induce arrhythmias, known as pro arrhythmia. Radiofrequency catheter ablation has become a well-established therapy for the treatment of supraventricular tachycardia. The reported success rate is over 90%, although catheter mapping in the left ventricle is difficult in patients with hypertrophic cardiomyopathy because of the marked left ventricular wall thickening associated with bizarre myocardial hypertrophy with disorganization, the abundant capillary muscle networks, and annoying ventricular arrhythmias. This report documents catheter mapping technique of radio frequency ablation in patients with hypertrophic cardiomyopathy and supraventricular tachycardias. Kluwer Academic Publishers, 1996 catheter ablation nationallicence hypertrophic cardiomyopathy nationallicence supraventricular tachycardia nationallicence sudden death nationallicence WPW syndrome nationallicence Kinoshita Osamu 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut Sekiguchi Morie 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut Isobe Mitsuaki 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut Takenaka Hiroaki 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut Yazaki Yoshikazu 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut Imamura Hiroshi 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut Cardiovascular Drugs and Therapy Kluwer Academic Publishers 10/5(1996-11-01), 527-530 0920-3206 10:5<527 1996 10 10557 https://doi.org/10.1007/BF00050992 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF00050992 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Kinoshita Osamu 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut NATIONALLICENCE 700 1- Sekiguchi Morie 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut NATIONALLICENCE 700 1- Isobe Mitsuaki 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut NATIONALLICENCE 700 1- Takenaka Hiroaki 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut NATIONALLICENCE 700 1- Yazaki Yoshikazu 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut NATIONALLICENCE 700 1- Imamura Hiroshi 1st Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan aut NATIONALLICENCE 773 0- Cardiovascular Drugs and Therapy Kluwer Academic Publishers 10/5(1996-11-01), 527-530 0920-3206 10:5<527 1996 10 10557 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer